“Novartis has not established on the current record that it is likely to suffer irreparable harm if injunctive relief is not granted,” U.S. District Judge Dabney L. Friedrich wrote in her memorandum opinion denying Novartis’s motion for a preliminary injunction without prejudice.
Leave a Reply